UPLC-QTOF/MSE and Bioassay Are Available Approaches for Identifying Quality Fluctuation of Xueshuantong Lyophilized Powder in Clinic

• Main Authors: Zhi-Rui Yang (Author), Zi-Hao Wang (Author), Jin-Fa Tang (Author), Yan Yan (Author), Shi-Jun Yue (Author), Wu-Wen Feng (Author), Zheng-Yuan Shi (Author), Xin-Tong Meng (Author), Cheng Peng (Author), Chang-Yun Wang (Author), Da-Li Meng (Author), Dan Yan (Author)
• Format: Book
• Published: Frontiers Media S.A., 2018-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Xueshuantong Lyophilized Powder (XST), consisting of a series of saponins extracted from Panax notoginseng, is widely applied to treat acute cerebral infarction, stroke, and coronary heart disease in China. However, most adverse drug reactions (ADR) in clinic are caused by quality problems of XST. I...